FDA NDC Directory · JSON-LD · Markdown

Cardiolite

NDC 11994-001 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameTETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
Labeler / ManufacturerLantheus Medical Imaging, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA019785
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE (1 mg/mL)
Marketing started19901220
Package count2

External sources

Source: openFDA. Public-domain (CC0).